About Mithra Pharmaceuticals S.A.

Company Description

We are committed to providing women new choices improving their daily life

For over twenty years, Mithra has dedicated its researches so as to redefine women’s health by bringing innovative products in the fields of contraception and menopause.

Today, Mithra counts two complementary platforms: its portfolio of innovative products based on Estetrol (E4) and its portfolio of Complex Therapeutics. The whole supported by the Mithra CDMO, a technological platform offering a wide range of services going from pharmaceutical development to commercial manufacturing.

Since the launch of the first generic contraceptive pill in Belgium, Mithra always focused on innovation for women.

After years of research and development, our pipeline today includes late-stage development products, potential blockbusters and complex therapeutics in the fields of contraception and menopause. These projects are powered by our Mithra CDMO, our unique R&D and manufacturing platform.

Year founded


Served area




Shareholder information

Shares outstanding



June 30, 2015

Stock exchange(s)

Euronext Brussels



Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.